Navigation Links
Hanger Reports First Quarter 2013 Results
Date:5/1/2013

million, or 7.1%, was the result of a $16.7 million, or 9.5%, increase in the Patient Care segment, partially offset by a $1.3 million, or 3.0%, decrease in the Products & Services segment.  The $16.7 million increase in Patient Care segment sales was comprised of a $3.0 million, or 1.7%, increase in same center sales, with the remaining $13.7 million increase driven primarily by acquisitions closed in the prior year.  Patient Care was performing against strong 7.1% same center sales growth in the first quarter of 2012 and was negatively impacted by severe weather during the quarter.  The 3.0% decline in external Products & Services sales was a result of lower sales from the Company's distribution business, SPS, partially offset by increased sales from its rehabilitative solutions business, ACP.  The decline in sales at the distribution business resulted from a number of its largest independent O&P customers being acquired by the Patient Care segment during 2012, additional pressure put on independent O&P customers by the continuation of the CMS Recovery Audit Contractor (RAC) program, and the same weather conditions that negatively impacted the Company's Patient Care segment.

Income from operations for the quarter ended March 31, 2013 was $22.7 million, compared to $21.7 million in the prior year.  Excluding costs related to acquisitions and Janus, adjusted income from operations increased 5.9% to $23.2 million for the quarter ended March 31, 2013 from $21.9 million in the prior year. Adjusted income from operations as a percentage of revenue was 9.9% for the first quarter of 2013, which is relatively flat compared to the same period in 2012.

The Company's cash flow from operations increased $0.4 million to $1.7 million for the three months ended March 31, 2013 compared to a $1.3 million cash inflow for the same period in 2012.  As of March 31, 2013, the Company had $114.5 million in total liquidity, inclu
'/>"/>

SOURCE Hanger, Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Hanger, Inc. Announces First Quarter 2013 Earnings Release And Conference Call
2. Hanger Files Form 10-K for Year Ended December 31, 2012
3. Hanger Reports $0.62 Diluted EPS for the Fourth Quarter 2012
4. Hanger, Inc. Has Record Year In O&P Acquisitions:
5. Hanger Reports Earnings of $0.50 Per Diluted Share for the Third Quarter 2012
6. Hanger, Inc. Announces 2012 Year To Date Acquisitions Totaling $35.6 Million Of Annual Net Revenue
7. Hanger, Inc. Reports Earnings of $0.50 Per Diluted Share for the Second Quarter 2012
8. Hanger, Inc. Announces Second Quarter 2012 Earnings Release Conference Call
9. Hanger Orthopedic Group, Inc. announces name change to Hanger, Inc.
10. Hanger clinicians honored with 2012 Tribeca Disruptive Innovation Award
11. Covance Reports First Quarter Net Revenue Growth Of 9.3% To $580 Million, Pro Forma EPS Of $0.75 And Adjusted Net Orders Of $716 Million
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/4/2015)... , March 4, 2015  Tandem Diabetes Care®, Inc. ... manufacturer of the t:slim® and t:flex™ Insulin Pumps, today announced ... 6,037,500 shares of common stock at a price to the ... full by the underwriters of their option to purchase up ... the offering were offered by Tandem. BofA ...
(Date:3/4/2015)... GSI Group Inc. (NASDAQ: GSIG ... and supplier of precision photonics and motion control components ... technology markets, today reported financial results for the fourth ... financial results in this press release are GAAP measures ... fourth quarter of 2014, GSI generated revenue of $94.0 ...
(Date:3/4/2015)... MENLO PARK, Calif. , March 4, 2015 /PRNewswire/ ... biotechnology company in the emerging field of regenerative medicine, ... Chief Executive Officer, will ring The Opening Bell ® ... Thursday, March 5, 2015. Asterias began trading as an ... "New York Stock Exchange is a trusted ...
Breaking Medicine Technology:Tandem Diabetes Care Announces Closing of Underwritten Public Offering of Common Stock 2GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 2GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 3GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 4GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 5GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 6GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 7GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 8GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 9GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 10GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 11GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 12GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 13GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 14GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 15GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 16GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 17GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 18GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 19GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 20GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 21GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 22GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 23GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 24GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 25GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 26GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 27GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 28GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 29GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 30GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 31GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 32GSI Group Announces Financial Results for the Fourth Quarter and Full Year 2014 33Asterias Biotherapeutics to Ring Opening Bell at New York Stock Exchange 2Asterias Biotherapeutics to Ring Opening Bell at New York Stock Exchange 3
... American Medical Systems® (AMS) (NASDAQ: AMMD), a ... and female pelvic health, today announced it has received ... Welfare (MHLW) to market and distribute its GreenLight HPS® ... Hyperplasia (BPH), or enlarged prostate, in Japan. ...
... 2011 Misonix, Inc. (NASDAQ: MSON ), ... innovative, therapeutic, ultrasonic products worldwide for wound debridement, cosmetic ... applications, announced today that it will present at the ... 2011 at the Le Parker Meridien Hotel in New ...
Cached Medicine Technology:American Medical Systems' GreenLight HPS® Approved for Use in Japan 2Misonix to Present at the MDB Capital Bright Lights Conference on May 11, 2011 2
(Date:3/4/2015)... Dallas, Texas (PRWEB) March 04, 2015 ... materials, equipment, downstream client survey, marketing channels, industry ... basic overview of the industry, including spices definitions, ... and Chinese domestic market analysis are provided with ... landscape of the market. A comparison between the ...
(Date:3/4/2015)... CITY, GA (PRWEB) March 04, 2015 ... exclusive advanced microfiber technology and their first compression therapy ... huge success of this collection, SIGVARIS USA is proud ... the MIDTOWN MICROFIBER product line. , Constructed from a ... with all-day comfort in mind. These socks and thigh-highs ...
(Date:3/4/2015)... Port Richey, FL (PRWEB) March 04, 2015 ... Medical Detox cut the ribbon on their new facility in ... Pasco Chamber of Commerce. The new facility will allow the ... of helping end the prescription drug abuse epidemic through treatment ... current reality of drug addiction in the United States, we ...
(Date:3/4/2015)... March 04, 2015 Today Visiopharm announces ... , has joined the Visiopharm Board of Directors ... a time when we are positioned to become the ... for cancer diagnostics and research. , "Over ... the development and validation of ONCOtopix™ Dx, a complete ...
(Date:3/4/2015)... March 04, 2015 A new dieting ... promise in terms of extending life. Studies ... this new dieting routine can help extend life by ... clearly has long term benefits, many suffering from obesity ... quicker substitute is necessary. As an alternative to the ...
Breaking Medicine News(10 mins):Health News:World Spices Market Overview & Development 2015-2020 Now Available at DeepResearchReports.com 2Health News:World Spices Market Overview & Development 2015-2020 Now Available at DeepResearchReports.com 3Health News:Building on the Success of MIDTOWN MICROFIBER, SIGVARIS Expands Popular Compression Collection with Longer Foot Length Offerings 2Health News:Novus Medical Detox Hosts Ribbon Cutting Ceremony at Pasco County Facility 2Health News:Novus Medical Detox Hosts Ribbon Cutting Ceremony at Pasco County Facility 3Health News:Visiopharm Appoints Patrik Dahlen as Chairman of the Board 2Health News:Visiopharm Appoints Patrik Dahlen as Chairman of the Board 3Health News:Diet Doc Introduces New Alternative to the Feast and Famine Diet 2Health News:Diet Doc Introduces New Alternative to the Feast and Famine Diet 3
... show injury in as little as 6 days , , ... drug Tysabri can start causing liver damage within six days ... In January, the U.S. Food and Drug Administration expanded the ... of the digestive tract. , The drug has also been ...
... in a severe form of the disorder, , , WEDNESDAY, Feb. 27 ... and a more severe form of the disease caused by one ... are the two main findings from a Massachusetts study that found ... 35 babies a year before 2003 to less than 20 babies ...
... net premiums written increase 22% over the ... comparable year-earlier quarterly results, FARMINGTON, Conn., Feb. 27 ... today announced its financial results for the fourth quarter ended,December ... http://www.newscom.com/cgi-bin/prnh/20060829/NETU014LOGO ), -- Gross premiums written for ...
... (Nasdaq: ACUR ) announced that President and Chief,Executive ... for health,reasons for an as-yet undetermined period. Mr. Reddick ... Board of Directors. At the same time,the Company announced ... Chairman of the Board. Mr. Markham has been a ...
... Targeted Synergies Sells Rights to Bystolic(TM) (Nebivolol) for $370 ... To Consider a Sale of Dey ... MYL ),today announced its financial results for the three and nine ... for the Merck,Generics acquisition, and announced a number of strategic and ...
... 2008 Nektar,Therapeutics (Nasdaq: NKTR ) announced today ... ended December 31, 2007., Revenue totaled $65.8 million ... in the fourth quarter of 2006. For the year ... million compared to,$217.7 million in 2006., Cash, cash ...
Cached Medicine News:Health News:Tysabri May Cause Liver Damage, Health Officials Say 2Health News:Newborn Screening Suggests Decline in Cystic Fibrosis 2Health News:Newborn Screening Suggests Decline in Cystic Fibrosis 3Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $10.9 Million for the Fourth Quarter 2Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $10.9 Million for the Fourth Quarter 3Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $10.9 Million for the Fourth Quarter 4Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $10.9 Million for the Fourth Quarter 5Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $10.9 Million for the Fourth Quarter 6Health News:Darwin Professional Underwriters, Inc. Reports Record Net Income of $10.9 Million for the Fourth Quarter 7Health News:Acura Pharmaceuticals, Inc. Announces Andrew Reddick, President & CEO, To Take Medical Leave and Appointment of Richard Markham as Chairman of the Board 2Health News:Acura Pharmaceuticals, Inc. Announces Andrew Reddick, President & CEO, To Take Medical Leave and Appointment of Richard Markham as Chairman of the Board 3Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 2Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 3Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 4Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 5Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 6Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 7Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 8Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 9Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 10Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 11Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 12Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 13Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 14Health News:Mylan Reports Adjusted Diluted Cash EPS of $0.11 for the Quarter 15Health News:Nektar Therapeutics Announces Fourth Quarter and Year-End 2007 Financial Results 2Health News:Nektar Therapeutics Announces Fourth Quarter and Year-End 2007 Financial Results 3Health News:Nektar Therapeutics Announces Fourth Quarter and Year-End 2007 Financial Results 4Health News:Nektar Therapeutics Announces Fourth Quarter and Year-End 2007 Financial Results 5Health News:Nektar Therapeutics Announces Fourth Quarter and Year-End 2007 Financial Results 6Health News:Nektar Therapeutics Announces Fourth Quarter and Year-End 2007 Financial Results 7Health News:Nektar Therapeutics Announces Fourth Quarter and Year-End 2007 Financial Results 8Health News:Nektar Therapeutics Announces Fourth Quarter and Year-End 2007 Financial Results 9
Accepted by leading authorities as a simple and accurate method for discovering congenital color blindness of two type total color blindness and red/green blindness. This book is used for children an...
Stainless steel disposable retinal MVR blade, 10 pcs / box....
The only daily cleaner specially formulated with isopropyl alcohol to help dissolve lipids and oil-based make-up from contact lenses....
Clerz Plus helps retain moisture to relieve dryness and removes protein buildup from your lenses while you wear them for longer wear comfort....
Medicine Products: